BTG1 anticorps (PE)
Aperçu rapide pour BTG1 anticorps (PE) (ABIN2170715)
Antigène
Voir toutes BTG1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human BTG1
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
FCM: (1:20-100)
Optimal working dilution should be determined by the investigator. -
Commentaires
-
Exitation/Emission: 480,565nm/578nm
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 100 μg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at 4 °C for 12 months.
-
-
- BTG1 (B-Cell Translocation Gene 1, Anti-Proliferative (BTG1))
-
Autre désignation
- Btg1
-
Sujet
-
BTG1 belongs to the BTG family of proteins.FUNCTION: Anti-proliferative protein. Its expression is associated with the early G1 phase of the cell cycle. A chromosomal aberration involving BTG1 may be a cause of a form of B cell chronic lymphocytic leukemia, translocation t(8,12)(q24,q22) with MYC.
Synonyms: B cell translocation gene 1 protein, B cell translocation gene 1, anti prolerative, BTG1 protein, BTG1_HUMAN. -
ID gène
- 694
-
Pathways
- Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Antigène
-